AstraZeneca shoots for the stars, GSK wins first Zantac trial and PureTech Health launches tender at a premium
The long-awaited investor day at AstraZeneca (AZN) on 21 May delivered a punchy increase in the pharmaceutical giant's long term growth ambitions inviting further analysts upgrades to revenue and profit forecasts.After achieving its...
30 May 2024